Hepatobiliary MR contrast agent uptake as a predictive biomarker of aggressive features on pathology and reduced recurrence-free survival in resectable hepatocellular carcinoma: comparison with dual-tracer 18F-FDG and 18F-FCH PET/CT

Sebastien Mulé, Julia Chalaye, F. Legou, Arthur Tenenhaus, Julien Caldéraro, Athena Galletto Pregliasco, Alexis Laurent, Rym Kharrat, Giuliana Amaddeo, Hélène Regnault, Vania Tacher, Hicham Kobeiter, Emmanuel Itti, Alain Luciani